Abstract:Hepatitis C virus (HCV) is known to cause hepatitis and hepatocellular carcinoma. E2 envelope glycoprotein of HCV type (HCV-E2) has been reported to bind human host cells and is a major target for developing anti-HCV vaccines. However, the therapeutic vaccine for infected patients still needs further development. The vaccine aims to provide cytotoxic T-cells to eliminate infected cells and hepatocellular carcinoma. Currently, there is no effective HCV therapeutic vaccine because most chronically infected patients rarely generate cytotoxic T-cells, even though they have high levels of neutralizing antibodies. Therefore, the adjuvant must be applied to enhance the efficacy of the therapeutic vaccine. In this study, we constructed HCV1b-E2 recombinant protein, a truncated form of peptide, to combine with an effective vaccine adjuvant and delivery system by using poly d,l-lactic-co-glycolide (PLGA) microspheres. HCV1b-E2 protein was effectively encapsulated into PLGA microspheres (HCV1b-E2-PLGA) as a strategy to deliver an insoluble form of HCV1b-E2 protein. The size and shape of PLGA microspheres were generated properly to carry an insoluble form of viral peptide in vivo. The encapsulated viral protein was slowly and continuously released from PLGA microspheres, which indicated the property of the adjuvant. HCV1b-E2-PLGA can trigger a cell-mediated immune response by inducing an expression of mice CD8+ T-cells. Our results demonstrated that HCV1b-E2-PLGA-immunized mice have a significantly increased CD8+ T-cell number, whereas HCV1b-E2-immunized mice have a lower number of CD8+ T-cells. Moreover, HCV1b-E2-PLGA could induce a specific antibody to viral protein, and the immune cells could secrete IFN-γ, which is a significant cytokine for viral response. Thus, HCV1b-E2-PLGA is shown to have adjuvant property and efficacy in the murine model, which is a good strategy to develop HCV prophylactic and therapeutic vaccines.

Expression of HCV Structural Protein in Mammalian Cells

Retroviral Vector Mediated HCV E1E2 Envelope Protein Expression in Eukaryotic Cells and Animal Immune Experiment

Construction and expression of plasmids containing the truncated core protein of different quasispecies genotype 1b hepatitis C virus

Expression And Preliminary Application Of Hcvf Protein Gene

Expression of NS3/NS4A Proteins of Hepatitis C Virus in Huh7 Cells Following Engineering Its Eukaryotic Expression Vector

Expression of Vp2e and Vp3 Genes from Marine Birnavirus (MABV) in Insect Cells

Differential research of the seven different prokaryotic expression plasmid expressing the CORE protein of hepatitis C

Cloning,Expression of E2 Gene in Hepatitis C Virus Envelope Region and Significance of Anti-HCV E2 Detection in Patients with HCV Infection

Cellular Localization of HCBP1 and Its Interaction with HCV Core Protein in Vivo

Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV Virions.

[Expression of hepatitis C virus subunit fusion protein and analysis of its immunogenicity]

Construction of expression vector of hTERT/hIL-18 fusion gene in eukaryotic cells and its function]

[Development and Identification of the Recombinant Lentivirus Co-expressing HCV Structural Protein and Secreted Gaussia Luciferase (Gluc)].

[Expression of (His)(6)-Eif3s4 Fusion Protein in Human Breast Cancer Cell Bcap37].

Robust Production of Infectious Hepatitis C Virus (HCV) from Stably HCV Cdna-Transfected Human Hepatoma Cells

Construct Design, Biophysical, and Biochemical Characterization of the Fusion Core from Mouse Hepatitis Virus (a Coronavirus) Spike Protein

Expression of Hepatitis C Virus Envelope Protein 2 Induces Apoptosis in Cultured Mammalian Cells.

[Construction of Eukaryotic Expression Vector Expressing Hepatitis B Virus HBsAg and EGFP Fusion Protein and Establishment of Stable Transfected Chang Liver Cell Line].

Establishment and detection of a tetracycline-inducible stable cell line expressing hepatitis C virus nonstructural protein 5B

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

Hepatitis C Virus E2 Protein Encapsulation into Poly D, L-Lactic-co-glycolide Microspheres Could Induce Mice Cytotoxic T-cell Response.